'Functional Foods' A Fruitful Research Field, But Various Regulatory Obstacles Persist

But Various Regulatory Obstacles Persist Date: March 4, 1996 (The Scientist, Vol:10, #5, pg.1 & 8, March 4, 1996) (Copyright ©, The Scientist, Inc.) SIDEBAR : Functional Foods: An AG Biotech Boom? Life scientists are finding new opportunities to test wise words uttered by the ancient Greek physician Hippocrates: "Let your food be your medicine, and your medicine be your food." OPPORTUNITY KNOCKS: Louis Lasagna notes the field's potential. In academic and industry labs across the United

Written byKathryn Brown
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

But Various Regulatory Obstacles Persist Date: March 4, 1996
(The Scientist, Vol:10, #5, pg.1 & 8, March 4, 1996)
(Copyright ©, The Scientist, Inc.)

SIDEBAR : Functional Foods: An AG Biotech Boom?

Life scientists are finding new opportunities to test wise words uttered by the ancient Greek physician Hippocrates: "Let your food be your medicine, and your medicine be your food."

OPPORTUNITY KNOCKS: Louis Lasagna notes the field's potential. In academic and industry labs across the United States, researchers are hunting for the cancer-fighting ingredients in fruit, vegetables, and dietary fiber. These scientists are building the emerging field of "functional foods"-those with an added health benefit beyond traditional nutritional value. Functional food proponents like Stephen DeFelice, chairman of the Foundation for Innovation in Medicine (FIM)-a Cranford, N.J.-based nonprofit group that promotes natural therapies-put the field's market potential at up to $250 billion. Biomedical scientists say interdisciplinary research opportunities abound. "This ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies